This supports previous evidence suggesting that the mechanisms of APOE4 reflect a loss-of-function in the context of AD16,23,36, with APOE4 affecting biological pathways that are consistent with those linked to the polygenic component of AD. The gene discussed is APOE; the disease is Alzheimer disease.